Experiment: 7SFT

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	2 mM Integrin alpha-IIb light chain, 0.05 mM GST-filamin-Ig21	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 600
2	2D 1H-1H TOCSY	2 mM Integrin alpha-IIb light chain, 0.05 mM GST-filamin-Ig21	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 600
3	3D HN(CO)CA	1 mM [U-100% 13C; U-100% 15N] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900
4	3D CBCA(CO)NH	1 mM [U-100% 13C; U-100% 15N] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900
5	3D HCCH-TOCSY	1 mM [U-100% 13C; U-100% 15N] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900
6	3D HNCACB	1 mM [U-100% 13C; U-100% 15N] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900
7	3D 1H-15N NOESY	1 mM [U-100% 13C; U-100% 15N] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900
8	3D 1H-15N NOESY	1 mM [U-15N; U-2H] filamin Ig21, 2 mM Integrin alpha-IIb light chain	90% H2O/10% D2O	61 mM	6.4	1 atm	298	Bruker AVANCE 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
4	collection	TopSpin		Bruker Biospin
1	peak picking	Sparky		Goddard
3	chemical shift assignment	Sparky		Goddard
2	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.